Summary of the implied losses explicitly attributable to the B Cell Platform in only the last 5 years (i.e. costs go back further than 2020 and this doesn't include the millions spent on salaries etc):
It appears the B Cell platform has been officially axed; but to notify the market about this $39m impairment loss by way of a non-price sensitive presentation is egregious.
IMU Price at posting:
3.9¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)